|
1
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bertuccio P, Chatenoud L, Levi F, Praud D,
Ferlay J, Negri E, Malvezzi M and La Vecchia C: Recent patterns in
gastric cancer: A global overview. Int J Cancer. 125:666–673. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Polk DB and Peek RM Jr: Helicobacter
pylori: Gastric cancer and beyond. Nat Rev Cancer. 10:403–414.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fox JG, Rogers AB, Whary MT, Ge Z, Ohtani
M, Jones EK and Wang TC: Accelerated progression of gastritis to
dysplasia in the pyloric antrum of TFF2 −/− C57BL6 × Sv129
Helicobacter pylori-infected mice. Am J Pathol. 171:1520–1528.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ding SZ, Goldberg JB and Hatakeyama M:
Helicobacter pylori infection, oncogenic pathways and epigenetic
mechanisms in gastric carcinogenesis. Future Oncol. 6:851–862.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao XD, Lu YY, Guo H, Xie HH, He LJ, Shen
GF, Zhou JF, Li T, Hu SJ, Zhou L, et al: MicroRNA-7/NF-κB signaling
regulatory feedback circuit regulates gastric carcinogenesis. J
Cell Biol. 210:613–627. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cui R, Meng W, Sun HL, Kim T, Ye Z, Fassan
M, Jeon YJ, Li B, Vicentini C, Peng Y, et al: MicroRNA-224 promotes
tumor progression in nonsmall cell lung cancer. Proc Natl Acad Sci
USA. 112:pp. E4288–E4297. 2015; View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ohta K, Hoshino H, Wang J, Ono S, Iida Y,
Hata K, Huang SK, Colquhoun S and Hoon DS: MicroRNA-93 activates
c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by
directly inhibiting PTEN and CDKN1A. Oncotarget. 6:3211–3224. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu R, Gu J, Jiang P, Zheng Y, Liu X,
Jiang X, Huang E, Xiong S, Xu F, Liu G, et al: DNMT1-microRNA126
epigenetic circuit contributes to esophageal squamous cell
carcinoma growth via ADAM9-EGFR-AKT signaling. Clin Cancer Res.
21:854–863. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Liu C, Luo M, Zhang Z, Gong J, Li
J, You L, Dong L, Su R, Lin H, et al: Chemotherapy-Induced
miRNA-29c/Catenin-δ Signaling Suppresses Metastasis in Gastric
Cancer. Cancer Res. 75:1332–1344. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han TS, Hur K, Xu G, Choi B, Okugawa Y,
Toiyama Y, Oshima H, Oshima M, Lee HJ, Kim VN, et al: MicroRNA-29c
mediates initiation of gastric carcinogenesis by directly targeting
ITGB1. Gut. 64:203–214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng B, Liang L, Wang C, Huang S, Cao X,
Zha R, Liu L, Jia D, Tian Q, Wu J, et al: MicroRNA-148a suppresses
tumor cell invasion and metastasis by downregulating ROCK1 in
gastric cancer. Clin Cancer Res. 17:7574–7583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Robertson KD, Keyomarsi K, Gonzales FA,
Velicescu M and Jones PA: Differential mRNA expression of the human
DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to
S phase transition in normal and tumor cells. Nucleic Acids Res.
28:2108–2113. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He M, Fan J, Jiang R, Tang WX and Wang ZW:
Expression of DNMTs and genomic DNA methylation in gastric signet
ring cell carcinoma. Mol Med Rep. 8:942–948. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hermann A, Gowher H and Jeltsch A:
Biochemistry and biology of mammalian DNA methyltransferases. Cell
Mol Life Sci. 61:2571–2587. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang C and Fang G: MiR-148a promotes
myocardial differentiation of human bone mesenchymal stromal cells
via DNA methyltransferase 1 (DNMT1). Cell Biol Int. Jun
28–2017.(Epub ahead of print). View Article : Google Scholar
|
|
20
|
Joshi P, Jeon YJ, Laganà A, Middleton J,
Secchiero P, Garofalo M and Croce CM: MicroRNA-148a reduces
tumorigenesis and increases TRAIL-induced apoptosis in NSCLC. Proc
Natl Acad Sci USA. 112:pp. 8650–8655. 2015; View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hanoun N, Delpu Y, Suriawinata AA, Bournet
B, Bureau C, Selves J, Tsongalis GJ, Dufresne M, Buscail L,
Cordelier P, et al: The silencing of microRNA 148a production by
DNA hypermethylation is an early event in pancreatic
carcinogenesis. Clin Chem. 56:1107–1118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sakamoto N, Naito Y, Oue N, Sentani K,
Uraoka N, Zarni Oo H, Yanagihara K, Aoyagi K, Sasaki H and Yasui W:
MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and
indicates tumor invasiveness and poor prognosis. Cancer Sci.
105:236–243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu B, Lv X, Su L, Li J, Yu Y, Gu Q, Yan M,
Zhu Z and Liu B: MiR-148a functions as a tumor suppressor by
targeting CCK-BR via inactivating STAT3 and Akt in human gastric
cancer. PLoS One. 11:e01589612016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fiedler J, Batkai S and Thum T:
MicroRNA-based therapy in cardiology. Herz. 39:194–200. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song Y, Xu Y, Wang Z, Chen Y, Yue Z, Gao
P, Xing C and Xu H: MicroRNA-148b suppresses cell growth by
targeting cholecystokinin-2 receptor in colorectal cancer. Int J
Cancer. 131:1042–1051. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hino R, Uozaki H, Murakami N, Ushiku T,
Shinozaki A, Ishikawa S, Morikawa T, Nakaya T, Sakatani T, Takada
K, et al: Activation of DNA methyltransferase 1 by EBV latent
membrane protein 2A leads to promoter hypermethylation of PTEN gene
in gastric carcinoma. Cancer Res. 69:2766–2774. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang BG, Hu L, Zang MD, Wang HX, Zhao W,
Li JF, Su LP, Shao Z, Zhao X, Zhu ZG, et al: Helicobacter pylori
CagA induces tumor suppressor gene hypermethylation by upregulating
DNMT1 via AKT-NFκB pathway in gastric cancer development.
Oncotarget. 7:9788–9800. 2016.PubMed/NCBI
|
|
28
|
Mutze K, Langer R, Schumacher F, Becker K,
Ott K, Novotny A, Hapfelmeier A, Höfler H and Keller G: DNA
methyltransferase 1 as a predictive biomarker and potential
therapeutic target for chemotherapy in gastric cancer. Eur J
Cancer. 47:1817–1825. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qiu H, Yashiro M, Shinto O, Matsuzaki T
and Hirakawa K: DNA methyltransferase inhibitor 5-aza-CdR enhances
the radiosensitivity of gastric cancer cells. Cancer Sci.
100:181–188. 2009. View Article : Google Scholar : PubMed/NCBI
|
